Akyla AKYLA
Equity Research Advanced Materials / Metal-Matrix Composites Initiation of Coverage — LONG Last Updated: June 28, 2026

CPS Technologies Corp. (CPSH)

Capacity-led turnaround into defense/EV/semiconductor demand for AlSiC metal-matrix composites; FY2025 swing to GAAP profit is the inflection. Initiating LONG with a ~2x bridge.

Thesis

  1. The inflection already happened in the income statement. CPS swung from a -$3.14M GAAP net loss in FY2024 to +$0.42M net income in FY2025 on $32.6M revenue (+54% YoY), with gross profit going from -$0.12M to +$5.29M. The business crossed breakeven on volume — the operating model now has demonstrated leverage, not a hypothetical one.
  2. This is a capacity-constrained story, not a demand-constrained one. The May 2026 secondary (424B5, filed 2026-05-29) raises fresh equity explicitly to fund capacity expansion for AlSiC baseplates (power electronics for EV, rail, and defense) and HybridTech armor. Demand for metal-matrix composites in defense radar/avionics and EV/rail power modules is the secular pull; CPS's constraint has been throughput.
  3. PATH TO 2x: We bridge the ~$97M market cap to ~$190M (≈$10/sh) by mid-2028 via a tied-out chain — revenue scaling toward ~$50M on the new capacity, gross margin normalizing back toward the high-teens (FY2025 was 16.2%; FY2023-era peaks were higher), and a modest small-cap re-rating to ~3.8x P/S. The math is shown explicitly in the Valuation section. It requires execution, not heroics.
  4. The comp set frames the re-rating optionality. Materials/display peers KOPN and OLED trade at 30.5x and 7.3x TTM P/S respectively; CPSH trades at ~3.0x TTM revenue today. We do NOT underwrite peer multiples — we use a conservative ~3.8x end-state — but the gap shows how a profitable, growing MMC franchise could re-rate.
  5. Honest about the air-pocket: Q1 2026 (period ending 2026-03-28) was soft — revenue $7.03M with gross margin collapsing to 8.6% and a return to a -$0.29M net loss. We treat this as a lumpy, project-driven quarter rather than a trend reversal, but the thesis is explicitly contingent on margin re-normalizing as volume and mix recover on the expanded capacity.

Continue reading

Read the full CPSH report

The full thesis — earnings detail, financial model, valuation and price target — is free. Enter your email to unlock the rest of the report.

Unlock the full report →

No account, no payment — just your email. For informational purposes only — not investment advice.

Disclaimer

This is not financial advice.

This report is for informational purposes only and is not investment advice.